Crescent Grove Advisors’s NCR Atleos NATL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.5M Buy
401,456
+13,048
+3% +$539K 1.68% 16
2025
Q4
$14.8M Sell
388,408
-62,686
-14% -$2.35M 1.37% 21
2025
Q3
$17.7M Sell
451,094
-98,181
-18% -$3.42M 1.68% 17
2025
Q2
$15.7M Sell
549,275
-5,768
-1% -$156K 1.52% 19
2025
Q1
$14.6M Buy
555,043
+226,010
+69% +$6.72M 1.53% 20
2024
Q4
$11.2M Sell
329,033
-619,355
-65% -$18.8M 1.11% 24
2024
Q3
$27.1M Sell
948,388
-51,119
-5% -$1.49M 2.76% 7
2024
Q2
$27M Sell
999,507
-228,037
-19% -$5.56M 2.96% 7
2024
Q1
$24.2M Buy
1,227,544
+9,466
+0.8% +$203K 2.53% 9
2023
Q4
$29.6M Buy
+1,218,078
New +$27.9M 3.3% 7

Other funds holding NATL

Crescent Grove Advisors's NATL Position: Q1 2026 in Review

Crescent Grove Advisors increased its NCR Atleos (NATL) stake by 3.4% in Q1 2026, buying an estimated $539K and bringing the position to 401,456 shares worth $17.5M. The position accounts for 1.68% of the portfolio, ranked #16.

Crescent Grove Advisors first reported a position in NATL in Q4 2023 and has held it in 10 quarters since. The position peaked at $29.6M in Q4 2023. 363 funds tracked by Wall St. Rank hold NATL as of Q1 2026.

  • Crescent Grove Advisors held 401,456 shares of NCR Atleos worth $17.5M as of Q1 2026.
  • Crescent Grove Advisors bought 13,048 NCR Atleos shares in Q1 2026, an estimated $539K.
  • NCR Atleos made up 1.68% of Crescent Grove Advisors's portfolio in Q1 2026, its #16 holding.
  • Crescent Grove Advisors first reported a position in NCR Atleos in Q4 2023 and has held it in 10 quarters since.
  • Crescent Grove Advisors's NCR Atleos position peaked at $29.6M in Q4 2023.
  • 363 funds tracked by Wall St. Rank held NCR Atleos as of Q1 2026.

Based on Crescent Grove Advisors's 13F filing for Q1 2026, filed 6 May 2026.